Key takeaways
- Foray Bioscience signed its first fabricated seed commercialization partnership.
- The agreement is with West Coast Chestnut, a tissue culture chestnut nursery.
- Fabricated seeds enable propagation from single plant cells into sowable embryos.
- The partnership targets faster time to market for chestnut varieties.
- The collaboration supports broader applications in reforestation and plant supply scaling.
Foray Bioscience Enters First Fabricated Seed Commercialization Partnership
Foray Bioscience announced its first seed partnership with West Coast Chestnut, marking the initial commercial deployment of Foray’s fabricated seed technology. The agreement follows validation of Foray’s approach to producing encapsulated plant embryos grown directly from plant cells that can be planted like conventional seeds.
According to the companies, the partnership reflects increasing demand for technologies that accelerate plant propagation and reduce the time required to bring new plant varieties to market.
Fabricated Seeds Designed To Accelerate Chestnut Propagation
Under the agreement, Foray Bioscience will develop fabricated seeds for select chestnut varieties. The goal is to shorten propagation timelines by enabling rapid bulking from single cells and reducing the acclimatization steps associated with traditional tissue culture methods.
